8 Jefferies Group Charles River Laboratories International Trades
Jefferies Group's position in Charles River Laboratories International is currently worth $1.44M. That's 0.02% of their equity portfolio (372nd largest holding). The first Charles River Laboratories International trade was made in Q3 2023. Since then Jefferies Group bought shares three more times and sold shares on four occasions. The investor's estimated purchase price is $1.75M, resulting in a loss of 18%.
News about Charles River Laboratories International Inc. and Jefferies Group
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River announces the launch of its Virtual Control Groups (VCG) initiative with Sanofi to redu...
Charles River Laboratories International, Inc. to Post Q1 2023 Earnings of $2.54 Per Share, Jefferies Financial Group Forecasts (NYSE:CRL)
Charles River Laboratories International, Inc. (NYSE:CRL ¨C Get Rating) ¨C Jefferies Financial Group cut their Q1 2023 earnings estimates for shares of Charles...
Equities Analysts Set Expectations for Charles River Laboratories International, Inc.¡¯s Q4 2022 Earnings (NYSE:CRL)
Equities research analysts at Jefferies Financial Group lowered their Q4 2022 earnings estimates for Charles River Laboratories International in a report rel...
Fragasso Group Inc. Sells 192 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Fragasso Group Inc. trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 0.8% in the 3rd quarter, according to its ...